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Abstract: Foot ulcers account for 15% of comorbidities associated with diabetes. Presently, 
no device allows the status of foot ulcers to be continuously monitored when patients are not 
hospitalized. In this study, we describe a temperature and a pH sensor capable of monitoring 
diabetic foot and venous leg ulcers developed in the frame of the seventh framework program 
European Union project SWAN-iCare (smart wearable and autonomous negative pressure 
device for wound monitoring and therapy). Temperature is measured by exploiting the varia-
tions in the electrical resistance of a nanocomposite consisting of multiwalled carbon nanotubes 
and poly(styrene-b-(ethylene-co-butylene)-b-styrene). The pH sensor used a graphene oxide 
(GO) layer that changes its electrical potential when pH changes. The temperature sensor has 
a sensitivity of ~85 Ω/°C in the range 25°C–50°C and a high repeatability (maximum standard 
deviation of 0.1% over seven repeated measurements). For a GO concentration of 4 mg/mL, 
the pH sensor has a sensitivity of ~42 mV/pH and high linearity (R2=0.99).
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Introduction
Diabetes is one of the most common diseases and its incidence is rapidly increasing. 
According to the 2015 edition of the IDF Diabetes Atlas, yearly published by the 
International Diabetes Federation, there are 415 million people worldwide with diabe-
tes and this number is expected to grow up to 642 million in 2040, with an estimated 
55% increase in 25 years.1 The diffusion of diabetes is not uniform in population. In 
the wealthiest countries, it mostly affects people .50 years of age, whereas it is more 
widespread among young people in middle-income countries.2
In 2015, ~5 million deaths of people could be ascribed to diabetes, mostly 
related to the comorbidities of the disease and its complications.1 Among the chronic 
complications of diabetes, the diabetic foot (DF), a chronic ulcerative condition, is 
the most prevalent and severe because it affects 25% of patients at least once in their 
life with a survival expectation less than that of many forms of cancer.3 DF ulcers are 
correlated to several risk factors, such as neuropathy (86% of cases), peripheral arterial 
disease (49% of cases), minor foot trauma, and foot deformity.4 The risk of amputa-
tion is not negligible; DF is the major cause of lower extremity amputations (LEAs) 
with a risk 20-fold higher than that of the general population and a limb amputated 
every 30 seconds.5
The healing rate of DF ulcers, defined as the rate of ulcers completely re-epithelized, 
stable for at least 2 weeks varies according to their pathogenesis,6 whereas the 
incidence is, depending on the reference population, 3%–5% for major amputa-
tions and 5%–40% for minor amputations. Another study reported that amputations 
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range from 2.1 to 13.7 per 1,000.7–9 The association of 
ischemia with infection increases 300% the risk of LEAs in 
DF ulcer patients, whereas DF ulcers precede LEAs in .85% 
of the cases.10 The impact of such ulcers on the patients’ 
quality of life is high, as they impair both personal and work 
relationships, with heavy psychological consequences.11 
In the United States, a substantial burden between $9 billion 
and $13 billion can be estimated for the health care system, 
summing the impact on private and public payers.12
Infection in DF ulcers is a major risk factor leading to 
amputation,10 and for this reason, the monitoring of the foot 
ulcers’ status may be of a great importance to ensure the 
effectiveness of therapies and the safety of patients. SWAN-
iCare (smart wearable and autonomous negative pressure 
device for wound monitoring and therapy) is a large-scale 
integrating European project seventh framework program 
that tackles the challenge of developing wearable devices and 
sensors to monitor and manage foot and venous ulcers.13,14 
The objective is to deliver a personalized therapy to patients 
whose ulcer status is remotely monitored so that a prompt 
action can be put in place in case of infection. The patient 
does not need to be hospitalized and can continue his/her 
normal life while a set of wearable sensors transmits the ulcer 
condition to a database accessible by clinicians. The sensors 
will monitor parameters such as transepidermal water loss 
of the perilesional skin, glucose, body temperature, skin and 
ulcer temperature, SpO
2
, levels of matrix metalloproteinases 
and bacteria, and the pH of the ulcer. There is a general 
consensus that there is a strong relationship between the 
ulcer temperature and the degradation of the ulcer status.15–19 
In fact, an increase in the basal temperature can be a warn-
ing of the ulcer onset even 1 week before it starts.20 Besides 
temperature, an increase of pH at the wound can also be a 
sign of infection as it is related to the presence of bacteria 
that proliferate in the ulcer.15,21–25
High precision handheld infrared thermographic scanners 
and cameras can be used to measure ulcer temperature. 
However, these devices are expensive and measurements 
are limited to research purposes. Presently, no wearable 
device is available to continuously monitor the ulcer 
temperature. Similar consideration can be made for the 
measurement of pH as the market only offers handheld pH 
meters.
This study describes the technologies and principles of 
the temperature and pH sensors that are under development 
in the SWAN-iCare project. We report the sensing materials 
under investigation and their early performances for a future 
use to fabricate wearable sensors for monitoring DF ulcers.
Materials and methods
Temperature
A temperature-sensitive nanocomposite material was 
prepared consisting of a conducting phase of multiwalled 
carbon nanotubes (MWCNTs, Baytubes C150 P) dispersed 
in toluene within an insulating phase of a thermoplastic 
elastomer, poly(styrene-b-(ethylene-co-butylene)-b-
styrene) (SEBS, Europrene Sol TH 212). In these kinds 
of materials, temperature variations lead to changes in the 
electrical resistance, so that they can be used to fabricate 
temperature sensors.26–29 A digital multimeter was used for 
log resistance values (Model 2700, Keithley) and a ther-
mostatic bath (F 32, Julabo) as a reference temperature. A 
dispersion of MWCNTs–SEBS was obtained as reported 
in a study by Matzeu et al.26 A volume equal to 10 µL of 
the dispersion was drop casted onto a pair of gold elec-
trodes (length of 7 mm) and let dry at room temperature 
to obtain a film (Figure 1). The electrodes were fabricated 
onto a Kapton® substrate (thickness of 50 µm; CAD Line, 
Pisa, Italy). Copper tracks were obtained by photolithog-
raphy and electroplated with nickel and gold to fabricate 
the electrodes (thickness of copper 35 µm, nickel 3.0 µm, 
and gold 1.2 µm). The nanocomposite film was annealed 
at 145°C for 4 hours. This treatment decreases sensitivity 
but improves stability, that has been identified as a major 
problem in the previous study,30 resulting in more accurate 
measurements.31
ph
We exploited the potentiality of graphene oxide (GO, Gra-
phenea) to measure pH because this material changes its 
potential in water solution when the pH changes.32 Figure 2 
shows the substrate used for the tests. A GO layer coated the 
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Figure 1 The temperature sensor.
Notes: left: drawing of the Kapton substrate for the temperature sensor. right: 
substrate with an electrode pair coated by a film of MWCNTs–SEBS.
Abbreviations: MWcNTs, multiwalled carbon nanotubes; seBs, poly(styrene-b-
(ethylene-co-butylene)-b-styrene).
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working electrode (WE) of a screen printed-board (C220BT, 
33×10×0.5 mm, Dropsens). This board has gold counter 
electrode (CE) and WE (diameter 4 mm), whereas the ref-
erence electrode (RE) consists of Ag/AgCl. The electrical 
contacts are in silver. The pH was measured as the change 
of the open circuit potential between the WE and the RE 
(Palmsens3, Palmsens). Five microliters of a GO dispersion 
in water was deposited onto the WE and let dry at room 
temperature. The sensor was compared with a commercial 
pH meter (Basic 20 by Crison with Micro P glass electrode 
by XS Sensor) in Hank’s Balanced Salt Solutions (HBSS; 
Sigma-Aldrich). Different pH values were obtained adding 
NaOH and HCl solutions.
Results
As SEBS is an insulating thermoplastic elastomer that expands 
or shrinks with temperature, this effect lead to changes in 
the topology of the MWCNT network. Temperature affected 
the electrical resistance of the film due to two main concur-
rent phenomena. In the first place, MWCNTs change their 
intrinsic resistance with temperature. Different behaviors were 
observed in different kinds of carbon nanotubes (eg, zigzag 
and armchair),33 but the MWCNTs showed a semiconduc-
tor behavior with a decrease of resistance at increasing 
temperatures. In the second place, the electrical resistance 
changed due to the different thermal expansion coefficients 
of the insulating phase (polymer matrix) and the conducting 
phase (MWCNTs), that led to a rearrangement of the topology 
of the network at different temperatures. SEBS shows a small 
but significant percentage of crystalline phase that melts just 
above room temperature,29 reinforcing the rubbery character 
of the material. The mobility of the MWCNTs is enhanced 
in a more “fluid” polymer matrix, and this makes it easier 
for individual nanotubes to connect each other leading to 
the decrease of the resistance that had been observed within 
different measurement cycles.26 The relative importance of 
this contribution has been strongly reduced by the annealing 
treatment and paying the price of a reduced sensitivity to 
improve the stability of the films and to obtain more reproduc-
ible measurements. Figure 3A shows the transmission electron 
microscopy (TEM) image (CM12, Philips) of MWCNTs–
SEBS after a sonication of 5 minutes. SEBS is not visible 
during TEM analysis; however, Figure 3A allows the good 
dispersion of MWCNTs in SEBS to be confirmed.
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Figure 2 screen-printed board used for the ph measurement.
Notes: The We is coated with a graphene oxide layer. The re is ag/agcl.
Abbreviations: ce, counter electrode; re, reference electrode; We, working 
electrode.
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Figure 3 TeM and seM images of MWcNTs-seBs and graphene oxide, respectively.
Notes: (A) TeM image of a MWcNTs–seBs composite after a 5-minute sonication. The MWcNTs are well dispersed (seBs are not visible in TeM). (B) scanning electron 
microscopy image of a graphene oxide layer.
Abbreviations: MWcNTs, multiwalled carbon nanotubes; seBs, poly(styrene-b-(ethylene-co-butylene)-b-styrene); TeM, transmission electron microscopy; seM, scanning 
electron microscope.
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Figure 4 shows the calibration curve for an annealed 
nanocomposite MWCNTs–SEBS (20% w/w of MWCNTs) 
obtained over seven repeated measurement cycles, from 
minimum to maximum temperature and vice versa. The 
maximum standard deviation was 0.08°C in the interval °C. 
The sensitivity was ~85 Ω/°C, and the response time was 
30 s/°C. The error calculated using this calibration curve 
was 0.3°C±0.2°C.
We tested three different GO concentrations to assess the 
sensitivity to pH. Figure 5 shows the calibration curves for 
different pH values at GO concentrations of 0.04, 0.4, and 
4 mg/mL. Figure 3B shows the scanning electron microscope 
(SEM) image (XL30, Philips) of a GO film (thickness ~90 nm) 
for a concentration of 4 mg/mL. In a recent study,34 we 
reported as the sensor was able to record pH over 3 days in 
human plasma. The same sensor was used after 20 days from 
immersion in plasma for another 3-day measurement cam-
paign and observed a difference of only 0.14±0.09 pH units 
compared with the commercial pH meter (Figure 6).
Discussion
The temperature sensor showed a high linearity (R2=0.999) 
and sensitivity (~85 Ω/°C) between 25°C and 50°C. The 
annealing improved both the linearity and the repeatability, 
thus indicating a stabilization of the nanocomposite micro-
domains. The size and shape of the Kapton substrate can 
be adapted to the dimension of the foot ulcer cavity for a 
smooth insertion. Before testing the sensor on patients, a 
protection coating should be applied onto the MWCNTs–
SEBS nanocomposite. The role of the coating is twofold: it 
serves as a protection layer to avoid the nanocomposite to 
be damaged and to guarantee the biocompatibility in contact 
with the ulcer. For this purpose, a layer of Parylene C could 
be used because its biocompatibility is already established in 
the literature, although its effect on the shrinkage/expansion 
of the nanocomposite should be investigated.34,35
The pH sensor proved to be suitable for pH measurement 
during laboratory tests. When the concentration of GO was 
increased up to 4 mg/mL, the sensitivity (~43 mV/pH), 
linearity (R2=0.99), and repeatability (three measurements 
per pH value, ±0.2 pH units) improved. These results are 
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Figure 4 calibration curve of a 20% w/w multiwalled carbon nanotubes– poly(styrene-
b-(ethylene-co-butylene)-b-styrene) nanocomposite.
\ ±[5 




9ROW
DJH
P9

S+        
9ROW
DJH
P9
 \ ±[5 





S+        
\ ±[5 





9ROW
DJH
P9

S+        
$ %
&
Figure 5 calibration curves for three gO ph sensors obtained at three different gO concentrations: (A) 0.04 mg/ml, (B) 0.4 mg/ml, and (C) 4 mg/ml.
Note: sensitivity increases with increasing concentrations.
Abbreviation: gO, graphene oxide.
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sufficient for considering this sensor as a potential candidate 
for tests on patients. The GO biocompatibility of this sensor 
has not yet been assessed, but a study suggested that at con-
centration ,20 µg/mL, the GO should not be cytotoxic.36
Conclusion
In this study, we described two temperature- and pH-sensitive 
materials that may be used to monitor chronic ulcers status 
over time. The Kapton board is suitable to be used for tests with 
patients and part of future work will be dedicated to design a 
Kapton board where both sensors can be fabricated.
The tests performed in laboratory showed promising 
results, but we are aware that these sensors still need to be 
clinically validated; however, some pivotal experiences with 
non-wearable temperature sensors on DF patients in a real 
clinical setting have already demonstrated how profitable 
such an information could be in terms of a better understand-
ing of the clinical course of the disease, that encompass both 
chronic sub-clinical phases and acute phases that are mostly 
triggered by super-infection of chronic ulcers and of improv-
ing the clinical outcomes because of the timely modifications 
of local and systemic therapies.17–19
Therefore, the possibility of introducing wearable 
sensors, eventually embedded in dressings or bandaging, 
for a real-time monitoring of variables such as pH and 
temperature in DF-ulcerated patients could help clinicians 
in improving the quality of treatments for such a complex 
pathology, specially increasing the timeliness of interven-
tion, that has been demonstrated to be directly correlated 
to its effectiveness, both in terms of reduction of LEAs and 
healing of the ulceration.37–39 Future work will be to perform 
a randomized controlled trial, including a sterilization process 
for the materials; to confirm this hypothesis; and to validate 
this new technology with clinical evidence.
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